BIOMAT Database Logo BIOMAT Database Logo

[Clinical use of pindolol (Visken) in the treatment of arterial hypertension]. 1977

I S Lambić, and Lj Krstić

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

I S Lambić, and Lj Krstić
[Visken in the treatment of arterial hypertension].
December 1975, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I S Lambić, and Lj Krstić
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
December 1973, European journal of clinical pharmacology,
I S Lambić, and Lj Krstić
[Pindolol in the treatment of arterial hypertension].
January 1978, Minerva medica,
I S Lambić, and Lj Krstić
[Pindolol in the treatment of arterial hypertension].
January 1979, La Revue du praticien,
I S Lambić, and Lj Krstić
[Pindolol in the treatment of arterial hypertension].
April 1977, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
I S Lambić, and Lj Krstić
[Effect of pindolol (Visken) on plasma and blood volume in men with primary arterial hypertension].
September 1985, Polski tygodnik lekarski (Warsaw, Poland : 1960),
I S Lambić, and Lj Krstić
[Effect of treatment with pindolol (Visken) on hemodynamics in patients with primary hypertension].
January 1986, Kardiologia polska,
I S Lambić, and Lj Krstić
[Pindolol-clopamide combination in the treatment of arterial hypertension. Clinical study].
January 1983, Therapie,
I S Lambić, and Lj Krstić
[Treatment of arterial hypertension by pindolol].
February 1976, La Nouvelle presse medicale,
I S Lambić, and Lj Krstić
Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
December 1975, European journal of clinical pharmacology,
Copied contents to your clipboard!